S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in
NASDAQ:DMTK

DermTech Earnings Date, Estimates & History

$48.70
-4.28 (-8.08 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$40.00
Now: $48.70
$56.56
50-Day Range
$38.00
MA: $56.49
$79.76
52-Week Range
$8.69
Now: $48.70
$84.49
Volume3.84 million shs
Average Volume1.55 million shs
Market Capitalization$954.28 million
P/E RatioN/A
Dividend YieldN/A
Beta0.99

Earnings

DermTech (NASDAQ:DMTK) Earnings Information

DermTech last released its quarterly earnings data on March 3rd, 2021. The reported ($0.47) earnings per share for the quarter, topping analysts' consensus estimates of ($0.54) by $0.07. DermTech has generated ($2.81) earnings per share over the last year.

DermTech Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DermTech (NASDAQ:DMTK) Earnings Estimates

2021 EPS Consensus Estimate: ($2.16)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20211($0.54)($0.54)($0.54)
Q2 20211($0.54)($0.54)($0.54)
Q3 20211($0.54)($0.54)($0.54)
Q4 20211($0.54)($0.54)($0.54)

DermTech (NASDAQ DMTK) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/3/202112/31/2020($0.54)($0.47)($0.48)Transcript
11/10/20209/30/2020($0.55)($0.50)($0.50)$1.22 million$1.36 millionListen
8/5/20206/30/2020($0.37)($0.58)($0.58)$0.84 millionN/A
5/13/20203/31/2020($0.46)($0.53)($0.53)$1.56 millionN/A
3/11/2020Q4 2019($0.08)($0.08)$1.59 millionN/A
11/7/2019Q2 2020($0.80)($0.80)$0.56 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/7/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.